Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4412-4417

  Merle, Harold ^a   Olindo, Stéphane ^a   Donnio, Angélique ^a   Richer, Raymond ^a   Smadja, Didier ^a   Cabre, Philippe ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR VISION; CONTROL GROUP; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EYE REFRACTION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CHARACTERISTICS AND FUNCTIONS; NERVE FIBER; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA NERVE CELL; SCORING SYSTEM; TECHNOLOGY; VISION; VISUAL ACUITY; OPTIC DISK; PATHOLOGY; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; RETINA GANGLION CELL;

ADULT; COLOR PERCEPTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NERVE FIBERS; NEUROMYELITIS OPTICA; OPTIC DISK; PERIMETRY; REFRACTION, OCULAR; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 53449084824     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1815     Document Type: Article

References (38)

1. Devic E. Myélite subaiguë compliquée de névrite optique. Bull Med. 1894;8:1033-1034.
2. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology. 2003;60:848-853.
3. Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007;114:810-815. (Pubitemid 46483673)
4. Sorensen TL, Frederiksen JL, Bronnum-Hansen H, Petersen HC. Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology. 1999;53:473-478. (Pubitemid 29382037)
5. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology. 2005;64:992-995.
6. Corallo G, Cicinelli S, Papadia M, et al. Conventional perimetry, short-wavelength automated perimetry, frequency-doubling technology, and visual evoked potentials in the assessment of patients with multiple sclerosis. Eur J Ophthalmol. 2005;15:730-738. (Pubitemid 43074699)
7. De Stefano N, Matthews PM, Antel JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol. 1995;38:901-909. (Pubitemid 26004072)
8. De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: results of a longitudinal magnetic resonance spectroscopy study. Brain. 1998;121:1469-1477. (Pubitemid 28349900)
9. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci. 2004;45:1716-1724. (Pubitemid 38868963)
10. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58:383-391.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53:1107-1114. (Pubitemid 29442132)
12. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485-1489.
13. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988;38:180-185.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231. (Pubitemid 13158528)
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: a expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
16. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnoses of multiples sclerosis. Ann Neurol. 2001;50:121-127.
17. Patella VM. STRATUSOCT: Establishment of normative reference values for retinal nerve fiber layer thickness measurements. Available at: http://www.zeiss.com.au/C1256C4F002FF302/EmbedTitelIntern/ EstablishmentofNormativeReference/$File/ EstablishmentOfNormativeReference.pdf.
18. Trobe JD, Beck RW, Moke PS, Cleary PA. Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol. 1996;121:547-553.
19. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vision Sci. 1988;1:187-199.
20. Beck RW, Diehl L, Cleary PA. The Optic Neuritis Study Group. The Pelli-Robson Letter Chart: normative data for young adults. Clin Vision Sci. 1993;8:207-210.
21. Balcer LJ, Baier ML, Cohen JA, et al. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology. 2003;61:1367-1373.
22. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324-332. (Pubitemid 43170783)
23. Sponsel WE, Arango S, Trigo Y, Mensah J. Clinical classification of glaucomatous visual field loss by frequency doubling perimetry. Am J Ophthalmol. 1998;125:830-836. (Pubitemid 28286083)
24. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol. 1982;93:635-642.
25. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805-815.
26. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin 4 water channel. J Exp Med. 2005;202:473-477.
27. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry. 2002;73:429-435.
28. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40:2520-2527. (Pubitemid 29455479)
29. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963-969. (Pubitemid 43830928)
30. Hickman SJ, Brierley CM, Brex PA, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler. 2002;8:339-342.
31. Hickman SJ, Wheeler-Kinshott CA, Jones SJ, et al. Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis. Am J Neuroradiol. 2005;26:951-956. (Pubitemid 43079798)
32. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006;31:286-293.
33. Kerrison JB, Flynn T, Green R. Retinal pathologic changes in multiple sclerosis. Retina. 1994;14:445-451.
34. Fardet L, Généreau T, Mikaeloff Y, et al. Devic's neuromyelitis optica: study of nine cases. Acta Neurol Scand. 2003;108:193-200. (Pubitemid 37011649)
35. Vernant JC, Cabre P, Smadja D, et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology. 1997;48:58-64. (Pubitemid 27039518)
36. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993;34:162-168. (Pubitemid 23223043)
37. Roemer SF, Parisi JE, Lennon VA, et al. Pattern specific loss of aquaporin 4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130:1194-1205. (Pubitemid 47355941)
38. Toth CA, Narayan DG, Boppart ST, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol. 1997;115:1425-1428.